Azenta Inc (AZTA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Azenta Inc (AZTA) has a cash flow conversion efficiency ratio of 0.008x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($12.18 Million) by net assets ($1.55 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Azenta Inc net asset quality index to measure how much of total assets are equity-financed.
Azenta Inc - Cash Flow Conversion Efficiency Trend (1994–2025)
This chart illustrates how Azenta Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check AZTA cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Azenta Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Azenta Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jefferson Capital, Inc. Common Stock
NASDAQ:JCAP
|
0.144x |
|
Nan Pao Resins Chemical Co Ltd
TW:4766
|
0.049x |
|
Compass Minerals International Inc
NYSE:CMP
|
0.720x |
|
ARB Corporation Ltd
AU:ARB
|
0.087x |
|
TF Bank AB
ST:TFBANK
|
-0.024x |
|
MRC Global Inc
NYSE:MRC
|
-0.070x |
|
Shanghai Film Co Ltd
SHG:601595
|
0.000x |
|
Indiamart Intermesh Limited
NSE:INDIAMART
|
0.131x |
Annual Cash Flow Conversion Efficiency for Azenta Inc (1994–2025)
The table below shows the annual cash flow conversion efficiency of Azenta Inc from 1994 to 2025. For the full company profile with market capitalisation and key ratios, see AZTA company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $1.73 Billion | $72.18 Million | 0.042x | +48.47% |
| 2024-09-30 | $1.77 Billion | $49.74 Million | 0.028x | +1121.63% |
| 2023-09-30 | $2.53 Billion | $5.83 Million | 0.002x | +101.66% |
| 2022-09-30 | $3.36 Billion | $-466.05 Million | -0.139x | -222.55% |
| 2021-09-30 | $1.33 Billion | $149.86 Million | 0.113x | +262.40% |
| 2020-09-30 | $1.21 Billion | $37.87 Million | 0.031x | -60.89% |
| 2019-09-30 | $1.14 Billion | $90.90 Million | 0.080x | -22.57% |
| 2018-09-30 | $717.83 Million | $73.96 Million | 0.103x | -34.93% |
| 2017-09-30 | $607.64 Million | $96.22 Million | 0.158x | +121.71% |
| 2016-09-30 | $553.69 Million | $39.55 Million | 0.071x | +3.24% |
| 2015-09-30 | $632.04 Million | $43.73 Million | 0.069x | -17.30% |
| 2014-09-30 | $642.89 Million | $53.78 Million | 0.084x | -2.69% |
| 2013-09-30 | $632.66 Million | $54.39 Million | 0.086x | +54.89% |
| 2012-09-30 | $649.30 Million | $36.04 Million | 0.056x | -67.16% |
| 2011-09-30 | $518.60 Million | $87.65 Million | 0.169x | +136.10% |
| 2010-09-30 | $389.35 Million | $27.87 Million | 0.072x | +140.50% |
| 2009-09-30 | $319.62 Million | $-56.49 Million | -0.177x | -802.04% |
| 2008-09-30 | $542.40 Million | $13.66 Million | 0.025x | -70.28% |
| 2007-09-30 | $860.24 Million | $72.87 Million | 0.085x | +3.89% |
| 2006-09-30 | $799.53 Million | $65.19 Million | 0.082x | -18.53% |
| 2005-09-30 | $310.89 Million | $31.11 Million | 0.100x | +254.67% |
| 2004-09-30 | $313.81 Million | $8.86 Million | 0.028x | +109.52% |
| 2003-09-30 | $162.99 Million | $-48.33 Million | -0.297x | -64.47% |
| 2002-09-30 | $308.73 Million | $-55.66 Million | -0.180x | -470.36% |
| 2001-09-30 | $424.93 Million | $20.68 Million | 0.049x | +253.31% |
| 2000-09-30 | $415.04 Million | $-13.18 Million | -0.032x | -182.90% |
| 1999-09-30 | $143.60 Million | $5.50 Million | 0.038x | +159.17% |
| 1998-09-30 | $121.80 Million | $1.80 Million | 0.015x | +199.16% |
| 1997-09-30 | $134.20 Million | $-2.00 Million | -0.015x | +64.02% |
| 1996-09-30 | $50.70 Million | $-2.10 Million | -0.041x | +76.53% |
| 1995-09-30 | $40.80 Million | $-7.20 Million | -0.176x | -164.71% |
| 1994-09-30 | $4.50 Million | $-300.00K | -0.067x | -- |
About Azenta Inc
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, in… Read more